Dr. Lorenza Rimassa
Claim this profileIstituto Clinico Humanitas
Area of expertise
Liver Cancer
Lorenza Rimassa has run 2 trials for Liver Cancer. Some of their research focus areas include:
Bile Duct Cancer
Lorenza Rimassa has run 2 trials for Bile Duct Cancer. Some of their research focus areas include:
Clinical Trials Lorenza Rimassa is currently running
Tinengotinib
for Bile Duct Cancer
This trial is testing an oral medication called Tinengotinib for patients with a specific type of bile duct cancer that has not responded to other treatments. The medication works by blocking a protein that helps cancer cells grow. The goal is to see if Tinengotinib can slow down or stop the cancer in these patients.
Recruiting
2 awards
Phase 3
Futibatinib
for Bile Duct Cancer
This is an open-label, multinational, randomized Phase 2 study confirming the clinical benefit of 20 mg futibatinib and evaluating the safety and efficacy of 16 mg futibatinib in previously treated CCA harboring FGFR2 gene fusions and other rearrangements.
Recruiting
1 award
Phase 2
More about Lorenza Rimassa
Clinical Trial Related
2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Lorenza Rimassa has experience with
- Durvalumab
- Tremelimumab
- NMS-01940153E
- 5-fluorouracil
- Aflibercept
- Folinic Acid
Breakdown of trials Lorenza Rimassa has run
Colorectal Cancer
Gallbladder Cancer
Biliary Tract Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Lorenza Rimassa specialize in?
Lorenza Rimassa focuses on Liver Cancer and Bile Duct Cancer. In particular, much of their work with Liver Cancer has involved Stage IV patients, or patients who are undergoing treatment.
Is Lorenza Rimassa currently recruiting for clinical trials?
Yes, Lorenza Rimassa is currently recruiting for 2 clinical trials in Rozzano MI. If you're interested in participating, you should apply.
Are there any treatments that Lorenza Rimassa has studied deeply?
Yes, Lorenza Rimassa has studied treatments such as Durvalumab, Tremelimumab, NMS-01940153E.
What is the best way to schedule an appointment with Lorenza Rimassa?
Apply for one of the trials that Lorenza Rimassa is conducting.
What is the office address of Lorenza Rimassa?
The office of Lorenza Rimassa is located at: Istituto Clinico Humanitas, Rozzano, MI 20133 Italy. This is the address for their practice at the Istituto Clinico Humanitas.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.